Grinberg et al. reported that PTXF could not inhibit tumor growth in immunodeficient (RAG1−/−) or CD8-depleted mice with melanoma [13], indicating that the inhibitory effect of PTXF on tumor growth is primarily mediated through its effect on immune cells. This evidence concerns the gene CD8A and neoplasm.